Allspring Global Investments
ATRA icon

Allspring Global Investments’s Atara Biotherapeutics ATRA Stock Holding History

Allspring Global Investments’s Portfolio ATRA Stock Details ATRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,559
Closed -$57.7K – 2252
2023
Q3 		$57.7K Sell
1,559
-1,097
-41% -$48.8K ﹤0.01% 2214
2023
Q2 		$107K Buy
2,656
+852
+47% +$48.2K ﹤0.01% 2025
2023
Q1 		$131K Sell
1,804
-24
-1% -$2.33K ﹤0.01% 1944
2022
Q4 		$150K Buy
1,828
+301
+20% +$31.4K ﹤0.01% 1919
2022
Q3 		$144K Buy
1,527
+379
+33% +$42.6K ﹤0.01% 1929
2022
Q2 		$223K Buy
1,148
+3
+0.3% +$490 ﹤0.01% 1783
2022
Q1 		$265K Sell
1,145
-755
-40% -$240K ﹤0.01% 2476
2021
Q4 		$748K Buy
+1,900
New +$800K ﹤0.01% 2110

Other funds holding ATRA

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Allspring Global Investments's ATRA Position: Q4 2023 in Review

Allspring Global Investments sold out of Atara Biotherapeutics (ATRA) in Q4 2023, closing a stake of 1,559 shares — an estimated $57.7K sold.

Allspring Global Investments first reported a position in ATRA in Q4 2021 and held it in 8 quarters. The position peaked at $748K in Q4 2021. 89 funds tracked by Wall St. Rank hold ATRA as of Q4 2023.

  • Allspring Global Investments reported no remaining Atara Biotherapeutics position as of Q4 2023 after selling out during the quarter.
  • Allspring Global Investments sold 1,559 Atara Biotherapeutics shares in Q4 2023, an estimated $57.7K.
  • Allspring Global Investments first reported a position in Atara Biotherapeutics in Q4 2021 and held it in 8 quarters.
  • Allspring Global Investments's Atara Biotherapeutics position peaked at $748K in Q4 2021.
  • 89 funds tracked by Wall St. Rank held Atara Biotherapeutics as of Q4 2023.

Based on Allspring Global Investments's 13F filing for Q4 2023, filed 25 Jan 2024.